BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

ReVance Therapeutics, Inc. 

2400 Bayshore Parkway, Suite 100

Mountain View  California  94043  U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
ReVance Therapeutics, Inc. Scores $33 Million in Series E Financing 4/2/2013 6:57:08 AM    More...
ReVance Therapeutics, Inc. Settles With Medicis (MRX) for Up to $25 Million, Regains Global Rights to Botulinum Toxin Products 10/8/2012 7:20:29 AM    More...
ReVance Therapeutics, Inc. Announces $45 Million Financing 6/10/2011 6:34:57 AM    More...
ReVance Therapeutics, Inc. Announces Clinical Trial Results of RT001 Topical Gel Presented at the Annual Meeting of the American Society for Dermatologic Surgery 10/25/2010 12:05:39 PM    More...
ReVance Therapeutics, Inc. (JOBS) Raises $25 Million 12/28/2009 8:21:49 AM    More...
Medicis (MRX) and ReVance Therapeutics, Inc. Announce Agreement for Development of Next-Gen Neurotoxin; Revance to Receive $10M and Additional Milestone Payments of $94M 7/29/2009 7:34:06 AM    More...
ReVance Therapeutics, Inc. Levers Up with $8 Million Financing 11/18/2008 8:11:52 AM    More...
ReVance Therapeutics, Inc. Announces Additional $8M Series C Expansion 5/12/2008 10:13:26 AM    More...
Medicis (MRX) and ReVance Therapeutics, Inc. Announce Strategic Collaboration 12/12/2007 8:52:34 AM    More...
ReVance Therapeutics, Inc. Announces Initiation Of Phase Ib Clinical Trial Of Topically Applied Botulinum Toxin Type A Gel For The Treatment Of Facial Aesthetics 11/9/2006 11:37:49 AM    More...
12